ABSTRACT
Objective@#To investigate the improving effect of astaxanthin (AST) on the sperm quality of rats with ornidazole (ORN)-induced oligoasthenozoospermiaand its action mechanism.@*METHODS@#Forty adult male SD rats were equally randomized into groups A (solvent control), B (low-dose ORN ［400 mg/（kg·d）］), C (high-dose ORN ［800 mg/（kg·d）］), D (low-dose ORN ［400 mg/（kg·d）］ + AST ［20 mg/（kg·d）］), and E (high-dose ORN ［800 mg/（kg·d）］ + AST ［20 mg/（kg·d）］), all treated intragastrically for3 weeks.After treatment, the epididymal tails ononeside was taken for determination of sperm concentration and activity, and the epididymideson the other side harvested for measurement of the activities of GSH-Px, GR, CAT and SOD and the MDA contentin the homogenate.@*RESULTS@#Compared with group A, sperm motilityin the epididymal tail andGSH-Px and SOD activities in theepididymiswere markedly decreased while the MDAcontent significantlyincreased in group B (P<0.05), spermmotility and concentrationin the epididymal tail, testisindex, and the activities of GSH-Px, GR, CAT and SOD in the epididymis were remarkably reduced while theMDA contentsignificantly increased in group C(P<0.05). In comparison with group B, group D showed markedly increased sperm motility (［45.3±8.7］% vs ［66.3±8.9］%, P<0.05) in the epididymal tail and SOD activity in the epididymis (［116.7±25.3］ U/mg prot vs ［146.1±23.8］ U/mg prot, P<0.05), decreased MDA content(［1.68±0.45］ nmol/mg prot vs ［1.19±0.42］ nmol/mg prot, P<0.05).Compared with group C, group Eexhibited significant increases in the weight gained (［89.0±9.5］ vs ［99.9±4.1］ %, P<0.05) and sperm motility (［17.9±3.5］% vs ［27.3±5.3］ %, P<0.05) but a decrease in the content of MDA (［2.03±0.30］ nmol/mg prot vs ［1.52±0.41］ nmol/mg prot, P<0.05).@*CONCLUSIONS@#AST can improve spermquality in rats with ORN-inducedoligoasthenozoospermia, which may be associated with its enhancing effect on the antioxidant capacity of the epididymis.
Subject(s)
Animals , Male , Rats , Antioxidants , Pharmacology , Asthenozoospermia , Epididymis , Metabolism , Oligospermia , Ornidazole , Oxidative Stress , Protective Agents , Pharmacology , Radiation-Sensitizing Agents , Random Allocation , Rats, Sprague-Dawley , Sperm Count , Sperm Motility , Spermatozoa , Metabolism , Xanthophylls , PharmacologyABSTRACT
Astaxanthin (AST) is a carotenoid with a strong antioxidant activity and has many biological functions, such as anti-inflammation, immune regulation, anti-tumor, anti-oxidation, anti-aging, and anti-apoptosis. Recent studies show that AST can effectively regulate the dynamic balance between oxidation and antioxidants in the male reproductive system, protect sperm mitochondrial function, ameliorate testicular heat stress and reproductive poison damage, promote the occurrence of sperm capacitation and acrosome reaction, regulate reproductive endocrine hormone balance, and act favorably on primary infertility or metabolic syndrome-related infertility. It also helps the treatment of late-onset hypogonadism and prostate health care. This review updates the studies of AST in male reproductive health and provides some new ideas for the prevention and treatment of male reproductive problems.